Selected article for: "expedite approval and sample size"

Author: Qingyang Xu; Shomesh Chaudhuri; Danying Xiao; Andrew W Lo
Title: Bayesian Adaptive Clinical Trials for Anti-Infective Therapeutics during Epidemic Outbreaks
  • Document date: 2020_4_14
  • ID: 20hk99h4_39
    Snippet: We first analyze the case when the infectivity remains constant in time (e.g. in the absence of effective NPIs). For the fixed-sample Bayesian RCT on a non-vaccine anti-infective therapeutic, as increases from 2 to 4 (Rows 1 to 2 of Table 3 ), the optimal sample size of each experimental arm decreases from 242 to 152 and the optimal Type I error rate drastically increases from 7.1% to 17.3% (Figure 1 ), much higher than the traditional 5% thresho.....
    Document: We first analyze the case when the infectivity remains constant in time (e.g. in the absence of effective NPIs). For the fixed-sample Bayesian RCT on a non-vaccine anti-infective therapeutic, as increases from 2 to 4 (Rows 1 to 2 of Table 3 ), the optimal sample size of each experimental arm decreases from 242 to 152 and the optimal Type I error rate drastically increases from 7.1% to 17.3% (Figure 1 ), much higher than the traditional 5% threshold. As the epidemic spreads across the population more rapidly, the Bayesian RCT model has greater pressure to expedite the approval process and a much higher tolerance of false positive outcomes.

    Search related documents:
    Co phrase search for related documents
    • anti infective therapeutic and sample size: 1, 2, 3
    • approval process and non vaccine anti infective therapeutic: 1
    • approval process and population spread: 1
    • approval process and sample size: 1
    • bayesian RCT model and RCT model: 1, 2, 3
    • bayesian RCT model and sample size: 1, 2
    • case analyze and population spread: 1
    • case analyze and sample size: 1
    • constant remain and population spread: 1
    • epidemic population spread and population spread: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • epidemic population spread and rapidly epidemic population spread: 1, 2
    • error rate and positive outcome: 1, 2, 3, 4
    • error rate and sample size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • experimental arm and sample size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • false positive outcome and positive outcome: 1, 2, 3, 4, 5, 6, 7
    • great pressure and population spread: 1
    • non vaccine anti infective therapeutic and sample size: 1
    • population spread and positive outcome: 1
    • population spread and rapidly epidemic population spread: 1, 2